LOS ANGELES, September 30, 2024 /PRNewswire/ — The Schall Law Firm, a formidable force in shareholder rights litigation, is urging investors to take the reins in a class action lawsuit against Outset Medical, Inc. (“Outset” or “the Company”) OM for purported violations of crucial securities regulations dating back to the seminal Securities Exchange Act of 1934.

If you are a shareholder who bore the brunt, seize the opportunity to make your voice heard. Reach out to the firm before October 28, 2024, to be part of the conversation that defines accountability.

For those affected, the clock is ticking. Click here to stand up and be counted.

Contact Brian Schall at the Schall Law Firm, situated at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067. Reach out at 310-301-3335 to unlock your rights, no strings attached. Alternatively, connect online at www.schallfirm.com, or email at bschall@schallfirm.com.

As this unfolds, remember—the class is not yet sanctioned. Until that pivotal green light, every action you take is pivotal. To opt for quietude is to simply fade into the background of this unfolding saga.

On the allegation front, it is believed that Outset misrepresented key elements. The Company projected its Tablo products as fitting for continuous renal replacement therapy, notwithstanding lacking FDA endorsement for this specific use. The narrative indicated an imminent 510(k) application submission to the FDA concerning Tablo, shrouded by the Company’s plan to suspend Tablo sales until clearance was obtained. An escalated Tablo selling effort was marred by the Company’s inability to galvanize a robust salesforce. This house of cards crumbled on the realization that Outset had peddled false narratives, leading investors down a rabbit hole of financial loss.

Don’t stand on the sidelines as the story unfolds. Your losses matter—be part of the movement to reclaim what is rightfully yours.

The Schall Law Firm’s purview spans the globe, specializing in the intricate domain of securities class action lawsuits and safeguarding shareholder rights.

One could argue that this publication may constitute Attorney Advertising in certain jurisdictions under the prevailing laws and ethical standards.

MEDIA CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

To access the original content and download multimedia, visit: https://www.prnewswire.com/news-releases/om-investors-have-opportunity-to-lead-outset-medical-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302262073.html

SOURCE The Schall Law Firm